Evidence map›Paper›PMID 40052329›Full record

ArticleJournal of the American Chemical Society2025

Multiprobe Photoproximity Labeling of the EGFR Interactome in Glioblastoma Using Red-Light.

Feifei Tong, Wuyue Zhou, Michalina Janiszewska, Ciaran P Seath

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. 2-Alkyl Furans Undergo Radiolytic Oxidative Protein Cross-Linking.Journal of the American Chemical Society · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Time-resolved photocatalytic proximity labeling uncovers ER proteome dynamics underlying UPR-to-apoptosis transition.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Feifei TongDepartment of Chemistry, Wertheim UF Scripps, Jupiter, Florida 33418, United States.ORCID 0009-0003-6872-7177
Wuyue ZhouDepartment of Chemistry, Wertheim UF Scripps, Jupiter, Florida 33418, United States.
Michalina JaniszewskaDepartment of Molecular Medicine, Wertheim UF Scripps, Jupiter, Florida 33418, United States.
Ciaran P SeathDepartment of Chemistry, Wertheim UF Scripps, Jupiter, Florida 33418, United States.ORCID 0000-0002-6774-128X

Funding

Photoproximity labeling as a tool for epigenetic drug discoveryR35GM150765 · NIGMS · UNIVERSITY OF FLORIDA · PI Ciaran Seath · 2023 to 2026
$1.9M
Vanquish Neo UHPLC for The Wertheim UF Scripps InstituteS10OD036363 · OD · UNIVERSITY OF FLORIDA · PI TSAPRAILIS, GEORGE · 2024 to 2024
$93k
NIGMS NIH HHS R35 GM150765NIH HHS S10 OD036363
6 · The paper itself

Abstract

Photocatalytic proximity labeling has emerged as a valuable technique for studying interactions between biomolecules in a cellular context, providing precise spatiotemporal control over protein labeling. One significant advantage of these methods is their modularity, allowing the use of a single photocatalyst with different reactive probes to expand interactome coverage and capture diverse protein interactions. Despite these advances, fewer methods have been developed using red-light excitation, limiting the use of photoproximity labeling in more complex media such as tissues and animal models. Herein, we develop a platform for proximity labeling under red-light excitation, utilizing a single catalyst and two distinct probe types. We first design a carbene based labeling system that utilizes sulfonium diazo probes. This system is successfully applied on A549 cells to capture the interactome of epidermal growth factor receptor (EGFR) using a Cetuximab-Chlorin e6 conjugate. Benchmarking against established techniques indicates that this approach performs comparably to leading carbene-based proximity labeling methods. Next, we leverage the strong singlet oxygen generation (SOG) ability of Chlorin e6 to establish an alternative labeling system using aniline and hydrazide probes. EGFR directed chemoproteomics experiments reveal significant overlap with the carbene system, with the carbene approach capturing a subset of interactions identified by the SOG system. Finally, we deploy our approach for the characterization of EGFR in resected human glioblastoma (GBM) tissue samples removed from distinct locations in the same tumor, representing the tumor's infiltrating edge and its viable center, identifying several GBM specific interacting proteins that may serve as a launch point for future therapeutic campaigns.

Indexed as

ErbB ReceptorsGlioblastomaLightCell Line, TumorCetuximabHumansMethanePorphyrinscarbeneCetuximabEGFR protein, humanErbB ReceptorsMethanePorphyrins

Identifiers

PMID40052329
PMCPMC12532021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.